Loading…
Lobbying Spend
—
Filings
7
Firms Hired
1
Active Period
2025–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · fourth_quarter · Firm: SPLITOAK STRATEGIES LLC
Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1 U.S. Competitiveness issues
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: SPLITOAK STRATEGIES LLC
Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1
Client expense: — · Firm income: $40,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: SPLITOAK STRATEGIES LLC
Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1 H.R.946/S.1862 - ORPHAN Cures Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1
Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1 H.R.946/S.1862 - ORPHAN Cures Act
Client expense: — · Firm income: $10,000
Matched citations: H.R.946
Value of prescription drugs and patient access Issues related to Medicaid, Medicare Parts B & D H.R. 1 H.R.946/S.1862 - ORPHAN Cures Act
Client expense: — · Firm income: $10,000
Matched citations: S.1862
Source: Senate LDA